Real World Insights

Providing Pharma & Biopharma with RWD & AI-Driven Insights on Patient Populations Affected by Speciality & Rare Diseases

Using Predictive Intelligence to Uncover the Rare Disease Patient Journey

In this podcast interview, Dan Fisher, managing director and practice lead for IPM.ai, explains the...

2023 Survey: Automation Is Ubiquitous for Orphan and Specialty Drug Commercialization

87% of Biopharma Respondents Use AI/ML for Post-Market Activities, But Key Missed Opportunities...

Using ML/AI to Find the Right Patients at the Right Time: A Conversation with AVEO Oncology

By: Dan Fisher, Principal, IPM.ai

Ganesh Rajaratnam, Senior Director of Commercial Operations,...

IPM.ai Recognized as One of the World’s Most Innovative Companies in 2022 by Fast Company

IPM.ai’s transformative approach to patient-finding for specialty and rare conditions captures the...

Ron Elwell, CEO and Founder of IPM.ai Wins MM+M’s Pinnacle Award

By: Dan Fisher, Principal, IPM.ai

Ron Elwell, CEO and founder of IPM.ai is a proud recipient of ...